The founding story
In April of 2021, I co-founded Iter Investments—a $20 million venture capital fund investing in companies focused on psychedelic medicine. My investment team realized very quickly that within the psychedelic industry there was a lack of connection between the “industry” and “the people”. We saw this gap as a major hindrance to the progression of psychedelics and their foreseeable impact on billions of lives.
This is where Nucleus comes in – My Investment Fund founded Nucleus as a venture studio that launches, acquires, or partners with assets that create the much needed connection between the people and the industry. We accomplish this lofty goal with our network of assets.
Nucleus's resources empowers all stakeholders in the psychedelic industry to transcend the lack of connection and cohesion that my team and I uncovered in early 2021.
Most of what we have accomplished or continue to strive for wouldn’t be remotely possible without our people. Our team consists of some of the most talented doctors, lawyers, scientists, writers, programmers, technologists, and marketing professionals in the industry.
With such deep experience and connection with institutional investors – Why are we crowdfunding?
Because we want our investor base to reflect the mission of Nucleus – connecting people to industry. By allowing a diverse group of passionate individuals the opportunity to invest into Nucleus, we will redistribute the power into the hands of you – the people. With your help we will accelerate the growth of the industry and ultimately heal billions of individuals.
Co-Founder, Iter Investments